Epithalon vs Thymalin: The Two Khavinson Peptides, Side by Side

Every figure is an all-in monthly price covering the medication, physician review, refill management and shipping. There is no separate membership fee, and Pepti is cash-pay and does not bill insurance. Current pricing always lives on each product page.

Both trace back to Vladimir Khavinson and Vyacheslav Morozov, who began work in 1973 at what became the St Petersburg Institute of Bioregulation and Gerontology. Their idea was that peptides extracted from a specific gland could support that gland's function in older bodies. Thymalin, from thymus tissue, was the first of the family. Epithalamin, from pineal tissue, came next, and epithalon is the synthetic tetrapeptide later designed to reproduce Epithalamin's amino-acid composition.

That shared origin shapes the evidence for both. Almost all of the literature comes from one research network and its collaborators, much of it in Russian-language journals, and the study designs are not the randomized, blinded trials Western regulators require. That does not make the work wrong. It means both should be read the same way: a long clinical tradition from one country, with mechanisms examined only recently elsewhere.

What it is

Epithalon is a tetrapeptide, Ala-Glu-Asp-Gly (AEDG), and one of the shortest peptides in clinical use. It is a single defined sequence that a chemist can synthesize. It is not melatonin, not a sedative and not a hormone. The full reference is at what is Epithalon.

How it is described to work

• Telomerase in cultured cells. A 2003 St Petersburg paper reported telomerase induction and telomere lengthening in cultured human fetal fibroblasts. A 2025 paper from Brunel University London in Biogerontology was the first independent replication in normal human cell lines, and also reported telomere extension in breast cancer cell lines.
• Evening melatonin where it is low. In old rhesus monkeys, a 2001 study reported evening melatonin rising more than fourfold; younger animals showed no change. The effect appears where melatonin output is already low and is absent where it is normal.
• Rodent lifespan. Anisimov and colleagues (Biogerontology, 2003) gave female mice brief monthly courses; mean lifespan did not change, the longest-lived ten per cent lived about 13 per cent longer, and overall tumour incidence was unchanged.

What it is

Thymalin is not a single sequence. It is a standardized mixture of short peptides extracted from the thymus of young cattle. The developers describe two dipeptides inside it, Lys-Glu (KE) and Glu-Trp (EW), as the active components. The thymus is where T-lymphocytes mature, and it shrinks steadily from puberty onward; the rationale is to supply thymic signalling peptides to a body whose own thymus has largely stopped producing them. The full reference is at what is Thymalin.

How it is described to work

• T-cell maturation. A 2020 paper in the Bulletin of Experimental Biology and Medicine reported human blood stem cells in culture shifting toward mature CD28-positive T-lymphocytes.
• Inflammatory cytokines. A 2023 paper in the International Journal of Molecular Sciences reported thymalin and its two dipeptides reducing IL-1 beta, IL-6 and TNF-alpha in stimulated human immune cells; a 2022 study described similar effects in a human monocyte line.
• Markers in hospital patients. Two Russian COVID-19 hospital studies (2021 and 2022) reported faster falls in IL-6, C-reactive protein and D-dimer with thymalin added to standard care. Neither abstract describes randomization or blinding.

The shared cohort, read carefully

The 2003 summary by Khavinson and Morozov in Neuro Endocrinology Letters followed 266 elderly people in St Petersburg and Kiev for six to eight years, treated for the first two to three years with thymalin, with Epithalamin, or with both. The live reports describe fewer respiratory infections and lower mortality in the treated groups, and larger differences for the combination. The epithalon reference gives mortality 1.6 to 1.8 times lower with Epithalamin alone; the thymalin reference gives 2.0 to 2.1 times lower with thymalin.

Three cautions apply to every one of those numbers. The pineal arm used Epithalamin, the extract, not synthetic epithalon. The programme was open-label and run by the institute that developed the products. And the abstracts describe no randomization, blinding or placebo, and no independent group has repeated it. It is the largest body of human experience with either compound. It is not a trial in the sense a regulator would use the word.

These two sisters have had completely different regulatory histories. As of the FDA pages checked in September 2026:

So epithalon has been through the process and is awaiting a decision, while thymalin has never entered it. Neither is banned, both remain legal to prescribe and dispense as compounded medications, and neither is FDA approved. Compounded medications are not FDA approved. Are peptides FDA approved explains the difference.

Both are drawn to 0.25 mL, which is 25 units on a U-100 insulin syringe, and injected under the skin once daily Monday through Friday, abdomen or thigh, rotating sites. Because the vials differ in strength, the same volume delivers different amounts.

The milligram figures are arithmetic from the label, not dosing advice. You do not need to calculate anything: your directions are printed on the vial, and your physician sets them after reviewing your intake. Twenty doses per vial is why refills run every 28 days, one vial per fill. Both ship refrigerated with ice packs, ready to use, with sterile syringes and alcohol prep pads.

Both research traditions used courses rather than open-ended daily use: epithalon in courses separated by months, thymalin in courses repeated annually in the older-adult programme. How long a course runs is set by your physician. More detail is in epithalon dosage.

Epithalon. Mostly injection-site redness, mild soreness and occasional bruising; some people report early drowsiness or vivid dreams. The FDA found no human safety study and no adverse-event reports, which is an absence of data, not evidence of safety, and raised a theoretical concern about long-term telomerase activation.

Thymalin. Mostly injection-site redness, mild soreness, occasional bruising or itching. As an animal-derived protein extract it carries a theoretical allergy risk a synthetic sequence does not, so a rash, hives or swelling beyond the injection site should be reported rather than waited out.

For either, swelling of the face or throat or difficulty breathing needs emergency care first (call 911), then tell your physician.

Neither compound has been shown in a controlled trial to extend life, prevent infections or slow ageing in people. Epithalon has a cell finding on telomerase that has now been independently replicated, animal melatonin and lifespan work, and human cohort data generated with a different preparation. Thymalin has cell work on T-cells and cytokines, the same cohort, and pandemic-era hospital reports without described randomization. Any provider describing either as proven is overstating it. The claim-by-claim reads are in epithalon benefits and thymalin benefits.

Neither can be bought legitimately without a prescription. Sites selling them "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with your directions printed on the vial.
5. Your physician stays reachable for questions and dose changes.

Pepti prescribes both in every state except Oklahoma, plus DC Step-by-step pages: how to get epithalon prescribed online and how to get thymalin prescribed online.